Mutant p53 Gains Its Function via c-Myc Activation upon CDK4 Phosphorylation at Serine 249 and Consequent PIN1 Binding.

Mutant p53 Gains Its Function via c-Myc Activation upon CDK4 Phosphorylation at Serine 249 and Consequent PIN1 Binding.
复制标题

突变体 p53 通过 CDK4 丝氨酸 249 磷酸化后的 c-Myc 激活以及随后的 PIN1 结合获得其功能

DOI:
10.1016/j.molcel.2017.11.006
复制
发表时间:
2017-12-21
期刊:
影响因子:
16
通讯作者:
Lu H
Lu H
中科院分区:
生物学1区
文献类型:
--
作者:
Liao P;Zeng SX;Zhou X;Chen T;Zhou F;Cao B;Jung JH;Del Sal G;Luo S;Lu H

文献摘要

参考文献

被引文献

相似文献

TP53错义突变通过不同机制获得新功能(GOF),显著影响各种人类癌症的发生和进展。在这里,我们报告了p53- r249s (p53- rs)的GOF的独特机制,p53- rs是人类肝细胞癌(HCC)中经常检测到的p53突变体,与乙型肝炎感染和黄曲霉毒素B1高度相关。CDK抑制剂阻断p53-RS在HCC中的核易位,而CDK4在细胞G1/S期与p53-RS相互作用,使其磷酸化,并增强其核定位。这与肽基脯氨酸顺式反式异构酶1 (NIMA-interacting 1, PIN1)与p53- rs结合结合,但不是p53形式,先前显示的4丝氨酸突变对PIN1的结合至关重要。因此,p53-RS与c-Myc相互作用,增强了c-Myc依赖性rDNA转录关键的核糖体生物发生。这些结果揭示了CDK4-PIN1-p53-RS-c-Myc通路作为HCC中p53-RS的GOF的新机制。Liao等的研究揭示了一种独特的分子通路,在HBV和黄曲霉毒素b1相关的人类肝癌中,肿瘤抑制因子p53在一个热点位点选择性突变,使突变的p53在促进肝癌细胞生长方面更具致癌作用。
TP53 missense mutations significantly influence the development and progression of various human cancers via their gain of new functions (GOF) through different mechanisms. Here we report a unique mechanism underlying the GOF of p53-R249S (p53-RS), a p53 mutant frequently detected in human hepatocellular carcinoma (HCC) that is highly related to hepatitis B infection and aflatoxin B1. A CDK inhibitor blocks p53-RS’s nuclear translocation in HCC, whereas CDK4 interacts with p53-RS in the G1/S phase of the cells, phosphorylates it, and enhances its nuclear localization. This is coupled with binding of a peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1) to p53-RS, but not the p53 form with mutations of 4 serines previously shown to be crucial for PIN1-binding. As a result, p53-RS interacts with c-Myc and enhances c-Myc-dependent rDNA transcription key for ribosomal biogenesis. These results unveil a CDK4-PIN1-p53-RS-c-Myc pathway as a novel mechanism for the GOF of p53-RS in HCC. The study by Liao et al unveils a unique molecular pathway that conveys selective mutation of the tumor suppressor p53 at a hot spot site solely found in HBV- and aflatoxin B1-associated human liver cancers and renders the mutated p53 more oncogenic in promoting liver cancer cell growth.
DOI: 10.1016/j.cell.2010.09.010
发表时间: 2010-10-15
期刊: Cell
影响因子: 64.5
作者:
Kim J;Woo AJ;Chu J;Snow JW;Fujiwara Y;Kim CG;Cantor AB;Orkin SH
通讯作者: Orkin SH
DOI: 10.1128/mcb.01455-12
发表时间: 2013-08-01
影响因子: 5.3
作者:
Farrell, Amy S.;Pelz, Carl;Sears, Rosalie C.
通讯作者: Sears, Rosalie C.
DOI: 10.1038/350429a0
发表时间: 1991-04-04
期刊: NATURE
影响因子: 64.8
作者:
BRESSAC, B;KEW, M;OZTURK, M
通讯作者: OZTURK, M
DOI: 10.1158/0008-5472.can-07-0529
发表时间: 2007-06-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Jung, Jin Kyu;Arora, Payal;Jang, Kyung Lib
通讯作者: Jang, Kyung Lib
DOI: 10.1016/0092-8674(89)90770-8
发表时间: 1989-12-22
期刊: CELL
影响因子: 64.5
作者:
CHISARI, FV;KLOPCHIN, K;PALMITER, RD
通讯作者: PALMITER, RD